Vivos (RDGL) Long-Term Investments (2010)
Vivos' (RDGL) quarterly Long-Term Investments came in at $10000.0 in Q4 2010.
Powered by 
Analysis
Vivos (RDGL) Long-Term Investments (2010) Analysis & Trends
Vivos has disclosed Long-Term Investments across 1 years of filings, most recently posting $10000.0 for Q4 2010.
- In Q4 2010, Long-Term Investments changed N/A year-over-year to $10000.0; the TTM figure through Dec 2010 stood at $10000.0 (changed N/A YoY), while the FY2010 annual figure was $10000.0, changed N/A from the prior year.
- Long-Term Investments came in at $10000.0 for Q4 2010 at Vivos.
- In the past five years, Long-Term Investments ranged from a high of $10000.0 in Q4 2010 to a low of $10000.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 2.25 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 244.10 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |